Guardant Health Wins $292.5 Million in Landmark False Advertising Case Against Rival Natera
San Francisco, California – In a decisive courtroom victory, Guardant Health, a prominent manufacturer of medical diagnostics, was awarded $292.5 million in damages on Monday. This followed a federal jury’s verdict that competitor Natera had engaged in false advertising concerning its colorectal cancer screening tests. The case, which captured industry and public attention, centered on accusations that Natera’s claims about its tests were misleading, thereby negatively impacting Guardant Health’s market standing and reputation. The substantial award consisted of both actual and punitive damages, highlighting the severity of the claims. This legal battle signifies a pivotal … Read more